s6y

8-K Material agreement; Director or officer change

Filed
Period
Accession number
0001213900-23-078339

Documents

  1. Current Report 8-K

Exhibits

  1. 2.3 Final Acquisition Agreement, Dated September 18, 2023, by and Between Adovate LLC and Adial Pharmaceuticals, Inc EX-2.3
Data files 4 Financial data and other files for software
  1. 101.SCH XBRL Schema File EX-101.SCH
  2. 101.DEF XBRL Definition File EX-101.DEF
  3. 101.LAB XBRL Label File EX-101.LAB
  4. 101.PRE XBRL Presentation File EX-101.PRE

On sec.gov